home / stock / cydy / cydy news


CYDY News and Press, CytoDyn Inc From 01/13/20

Stock Information

Company Name: CytoDyn Inc
Stock Symbol: CYDY
Market: OTC
Website: cytodyn.com

Menu

CYDY CYDY Quote CYDY Short CYDY News CYDY Articles CYDY Message Board
Get CYDY Alerts

News, Short Squeeze, Breakout and More Instantly...

CYDY - CytoDyn Files for Breakthrough Therapy Designation with the FDA for the Use of Leronlimab for the Treatment of Metastatic Triple-Negative Breast Cancer

VANCOUVER, Washington, Jan. 13, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced...

CYDY - The 1,100th Episode of MoneyTV with Donald Baillargeon, 1/10

HOLLYWOOD, CA / ACCESSWIRE / January 10, 2020 / Breast cancer and HIV treatment, solar, tequila awards, CBD cosmetics, cannabis products, 1,100 episodes; this week on MoneyTV with Donald Baillargeon. MoneyTV is the internationally syndicated television program all about money and what makes...

CYDY - CytoDyn to Deliver Presentation at Biotech Showcase Conference

VANCOUVER, Washington, Jan. 09, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced...

CYDY - CytoDyn: Buy, Sell, Or Hold Following PRO 140 Commercial Agreement

CytoDyn Inc. ( OTCQB:CYDY ) recently publicized that they have signed a U.S. commercial agreement with Vyera for PRO 140 in HIV indications. In return, CytoDyn will receive an upfront payment and milestone payments worth up to the royalty on net sales. This was one of the most anticipated ca...

CYDY - CytoDyn's Future Is Looking Brighter And Brighter: Entering A Transformational Year 2020

Editor's note: Seeking Alpha is proud to welcome Jannik Reiners as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA PREMIUM. Click here to find out more » Introduction ...

CYDY - The Real Value Of A Breakthrough Therapy Designation

The FDA Breakthrough Therapy Designation (BTD) was an offshoot of the Food and Drug Administration Safety and Innovation Act (FDASIA) that was signed on July 9, 2012 , that called for a new designation to be created. Since 2012, only 147 drugs have been approved having this designation, which...

CYDY - CytoDyn Reports Early, But Strong Positive Clinical Responses for Two Patients, One in Metastatic Breast Cancer and One in Metastatic Triple-Negative Breast Cancer Trials

VANCOUVER, Washington, Dec. 23, 2019 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced...

CYDY - Best Penny Stocks To Buy Before January? 1 Up 332% This Quarter

These Penny Stocks Are On A Roll Right Now When it comes to finding the best penny stocks to buy , you really have to consider your personal approach to the stock market. Are you a day-trader, do you prefer swing trading, do you scalp trades, or are you a true investor? All of these have defi...

CYDY - Penny Stocks To Trade After Breaking News; 1 Gained 339% This Week

Can These Penny Stocks Score Big After New Updates? One of the things that need to be kept in mind with regards to penny stocks is that these stocks give almost anyone the opportunity to make a fortune in the stock market. Though “fortune” is subjective to the eye of the behold...

CYDY - CytoDyn out-licenses U.S. rights to leronlimab for HIV for up to $87.5M

CytoDyn ( OTCQB:CYDY ) inks an agreement with privately held Vyera Pharmaceuticals related to HIV med leronlimab. More news on: CytoDyn Inc., Healthcare stocks news, Read more ...

Previous 10 Next 10